EUVIMEDEUVIMED entdecken
Crossref

Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder

Tianjiao Wang, Jingzhi Yang, Yuncheng Zhu, Na Niu, Binbin Ding, Ping Wang, Hongxia Zhao, Na Li, Yufan Chao, Songyan Gao, Xin Dong, Zuowei Wang

Journal of Affective Disorders · 2024-07 · 356 · 1-12

DOI: 10.1016/j.jad.2024.03.114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024-07. Verfasst von Tianjiao Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shanghai University, Shanghai 200444, China; Clinical Research Center for Mental Health, School of Medicine, Shanghai University,…. Hauptthemen laut MEDLINE: Bipolar Disorder, Major Depressive Disorder, Biomarkers, Metabolomics. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Major depressive disorder (MDD) and bipolar disorder (BD) are psychiatric disorders with overlapping symptoms, leading to high rates of misdiagnosis due to the lack of biomarkers for differentiation. This study aimed to identify metabolic biomarkers in urine samples for diagnosing MDD and BD, as well as to establish unbiased differential diagnostic models. METHODS: We utilized a metabolomics approach employing ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) to analyze the metabolic profiles of urine samples from individuals with MDD (n = 50), BD (n = 12), and healthy controls (n = 50). The identification of urine metabolites was verified using MS data analysis tools and online metabolite databases. RESULTS: Two diagnostic panels consisting of a combination of metabolites and clinical indicators were identified-one for MDD and another for BD. The discriminative capacity of these panels was assessed using the area under the receiver operating characteristic (ROC) curve, yielding an area under the curve (AUC) of 0.9084 for MDD and an AUC value of 0.9017 for BD. CONCLUSIONS: High-resolution mass spectrometry-based assays show promise in identifying urinary biomarkers for depressive disorders. The combination of urine metabolites and clinical indicators is effective in differentiating healthy controls from individuals with MDD and BD. The metabolic pathway indicating oxidative stress is seen to significantly contribute to depressive disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderMajor Depressive DisorderBiomarkersMetabolomicsMass SpectrometryHumansFemaleMaleAdultDiagnosis, DifferentialMiddle AgedChromatography, High Pressure LiquidROC CurveCase-Control Studies

Stichwörter der Autor:innen

Bipolar disorderDifferential diagnosisMajor depressive disorderMetabolomicsOxidative stress

Substanzen

Biomarkers

Autor:innen und Institutionen

  • School of Medicine, Shanghai University, Shanghai 200444, China; Clinical Research Center for Mental Health, School of Medicine, Shanghai University, Shanghai 200083, China.
  • Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.
  • Clinical Research Center for Mental Health, School of Medicine, Shanghai University, Shanghai 200083, China; Division of Mood Disorders, Shanghai Hongkou Mental Health Center, Shanghai 200083, China.
  • Division of Mood Disorders, Shanghai Hongkou Mental Health Center, Shanghai 200083, China.
  • Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang 524045, China.
  • School of Medicine, Shanghai University, Shanghai 200444, China.

Förderung

  • Shanghai Municipal Health Commission

Zitieren

APA

Wang, T., Yang, J., Zhu, Y., Niu, N., Ding, B., Wang, P., Zhao, H., Li, N., Chao, Y., Gao, S., Dong, X., & Wang, Z. (2024). Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder. Journal of Affective Disorders, 356, 1-12. https://doi.org/10.1016/j.jad.2024.03.114

Vancouver

Wang T, Yang J, Zhu Y, Niu N, Ding B, Wang P, et al. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder. Journal of Affective Disorders. 2024;356:1-12. doi:10.1016/j.jad.2024.03.114

BibTeX
@article{Wang2024,
  author = {Wang, Tianjiao and Yang, Jingzhi and Zhu, Yuncheng and Niu, Na and Ding, Binbin and Wang, Ping and Zhao, Hongxia and Li, Na and Chao, Yufan and Gao, Songyan and Dong, Xin and Wang, Zuowei},
  title = {Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder},
  journal = {Journal of Affective Disorders},
  year = {2024},
  volume = {356},
  pages = {1--12},
  doi = {10.1016/j.jad.2024.03.114}
}
Kostenlos starten →